Opioid Treatment Program (Otp) Consortium
Consortium of drug-treatment facilities.
Based in TX
🤖
AI Overview
With $320K in lobbying spend across 16 quarterly filings, Opioid Treatment Program (Otp) Consortium is an active lobbying client. Their lobbying covers 1 issue area. Active from 2018 to 2021.
$320K
Total Spend
4
Years Active
1
Firms Hired
3
Lobbyists Deployed
1
Issues Lobbied
Spending Trend
View as table
| Year | Lobbying Spend |
|---|---|
| 2018 | $80K |
| 2019 | $100K |
| 2020 | $80K |
| 2021 | $60K |
Issues Lobbied
Lobbying Firms
Lobbyists
What They Lobby About
These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Health Issues
- •Medicaid reform, health reform, funding and coverage for opioid use disorder treatment.
- •Medicaid reform, health reform, funding and coverage for opioid use disorder treatment.
- •H.R.6 - SUPPORT for Patients and Communities Act
Related Analysis
Related Investigations
Big Pharma's $452M Lobbying Machine
How pharmaceutical companies spend hundreds of millions to influence health policy.
Healthcare's $3 Billion Bet
The healthcare industry's massive lobbying investment.
Federal Lobbying Statistics 2025
The definitive stats — $37.7B total, industry breakdowns, and trends.
What Is Lobbying? A Complete Guide
How lobbying works, who does it, and why it matters.
Similar Clients
Explore More
Data Sources: Senate LDA Filings
Last updated: February 2026
This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.